CHARLES SCHWAB INVESTMENT MANAGEMENT INC - ALX ONCOLOGY HLDGS INC ownership

ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 58 filers reported holding ALX ONCOLOGY HLDGS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 2.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of ALX ONCOLOGY HLDGS INC
ValueSharesWeighting
Q3 2023$675,523
-45.7%
140,734
-15.0%
0.00%
Q2 2023$1,243,288
+82.8%
165,551
+10.0%
0.00%
Q1 2023$680,133
-62.3%
150,472
-5.9%
0.00%
-100.0%
Q4 2022$1,803,031
+24.3%
159,985
+5.6%
0.00%0.0%
Q3 2022$1,450,000
+18.1%
151,502
-0.1%
0.00%
Q2 2022$1,228,000
-45.6%
151,713
+13.7%
0.00%
-100.0%
Q1 2022$2,256,000
-25.0%
133,479
-4.6%
0.00%0.0%
Q4 2021$3,007,000
-70.6%
139,882
+0.8%
0.00%
-66.7%
Q3 2021$10,245,000
+102.1%
138,706
+49.6%
0.00%
+50.0%
Q2 2021$5,070,000
-24.4%
92,704
+1.9%
0.00%0.0%
Q1 2021$6,709,000
+8.0%
90,970
+26.3%
0.00%0.0%
Q4 2020$6,210,000
+184.0%
72,031
+24.4%
0.00%
+100.0%
Q3 2020$2,187,00057,9240.00%
Other shareholders
ALX ONCOLOGY HLDGS INC shareholders Q3 2020
NameSharesValueWeighting ↓
venBio Partners LLC 9,699,925$715,272,00067.97%
Logos Global Management LP 3,156,981$232,796,00022.72%
Vivo Capital, LLC 4,220,048$311,186,00010.94%
Foresite Capital Management IV, LLC 785,945$57,956,0006.94%
Foresite Capital Management V, LLC 320,000$23,597,0006.94%
Board of Trustees of The Leland Stanford Junior University 518,822$38,258,0003.38%
Cormorant Asset Management, LP 881,770$65,022,0001.45%
Redmile Group, LLC 978,600$72,162,0001.02%
SPHERA FUNDS MANAGEMENT LTD. 130,351$9,612,0000.74%
Artal Group S.A. 525,000$38,714,0000.68%
View complete list of ALX ONCOLOGY HLDGS INC shareholders